Trials / Unknown
UnknownNCT05191225
Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study
Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study - Intervention Pilot Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Laida Cuevas Palomares · Network
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this pilot study is therefore to assess the safety of Truxima ultrafast infusion within 30 minutes in patients with non-Hodgkin's lymphoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RiTUXimab Injection [Truxima] | 375 (mg/m2) / 60 minutes |
| DRUG | RiTUXimab Injection [Truxima] | 375 (mg/m2) / 30 minutes |
Timeline
- Start date
- 2021-09-28
- Primary completion
- 2022-03-01
- Completion
- 2022-12-01
- First posted
- 2022-01-13
- Last updated
- 2022-03-31
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05191225. Inclusion in this directory is not an endorsement.